Kirsty Ross Stewart

Stock Analyst at Exane BNP Paribas

(1.24)

# 3,637

Out of 4,574 analysts

Total ratings

50%

Success rate

-8.6%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Kirsty Ross Stewart

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ZLDPF Zealand Pharma A/S	Downgraded: Hold	$138 → $42	$45.01	-7.08%	2	Mar 6, 2026
	STO: SOBI Swedish Orphan Biovitrum AB (publ)	Upgraded: Buy	kr 475.00	kr 457.40	+3.85%	1	Feb 10, 2026

Zealand Pharma A/S

Mar 6, 2026

Downgraded: Hold

Price Target: $138 → $42

Current: $45.01

Upside: -7.08%

Swedish Orphan Biovitrum AB (publ)

Feb 10, 2026

Upgraded: Buy

Price Target: kr 475.00

Current: kr 457.40

Upside: +3.85%